| 1 | vr false login vitalrads® | | | | | | | 1 | 0.36% |
| 2 | when a diagnosis and | | | | | | | 1 | 0.36% |
| 3 | an option to support | | | | | | | 1 | 0.36% |
| 4 | option to support clinical | | | | | | | 1 | 0.36% |
| 5 | to support clinical findings | | | | | | | 1 | 0.36% |
| 6 | support clinical findings inhouse | | | | | | | 1 | 0.36% |
| 7 | clinical findings inhouse treatment | | | | | | | 1 | 0.36% |
| 8 | options are often expanded | | | | | | | 1 | 0.36% |
| 9 | are often expanded when | | | | | | | 1 | 0.36% |
| 10 | often expanded when using | | | | | | | 1 | 0.36% |
| 11 | expanded when using a | | | | | | | 1 | 0.36% |
| 12 | when using a telemedicineteleradiology | | | | | | | 1 | 0.36% |
| 13 | service when a diagnosis | | | | | | | 1 | 0.36% |
| 14 | a diagnosis and treatment | | | | | | | 1 | 0.36% |
| 15 | is often an option | | | | | | | 1 | 0.36% |
| 16 | diagnosis and treatment plan | | | | | | | 1 | 0.36% |
| 17 | and treatment plan for | | | | | | | 1 | 0.36% |
| 18 | treatment plan for a | | | | | | | 1 | 0.36% |
| 19 | plan for a patient | | | | | | | 1 | 0.36% |
| 20 | for a patient is | | | | | | | 1 | 0.36% |
| 21 | a patient is supported | | | | | | | 1 | 0.36% |
| 22 | by the report of | | | | | | | 1 | 0.36% |
| 23 | the report of a | | | | | | | 1 | 0.36% |
| 24 | report of a boardcertified | | | | | | | 1 | 0.36% |
| 25 | of a boardcertified specialist | | | | | | | 1 | 0.36% |
| 26 | a boardcertified specialist this | | | | | | | 1 | 0.36% |
| 27 | often an option to | | | | | | | 1 | 0.36% |
| 28 | to a boardcertified specialist | | | | | | | 1 | 0.36% |
| 29 | specialist this significantly boosts | | | | | | | 1 | 0.36% |
| 30 | specific specialty is required | | | | | | | 1 | 0.36% |
| 31 | backup of routine clinical | | | | | | | 1 | 0.36% |
| 32 | of routine clinical findings | | | | | | | 1 | 0.36% |
| 33 | routine clinical findings in | | | | | | | 1 | 0.36% |
| 34 | clinical findings in everyday | | | | | | | 1 | 0.36% |
| 35 | findings in everyday cases | | | | | | | 1 | 0.36% |
| 36 | in everyday cases or | | | | | | | 1 | 0.36% |
| 37 | for tough cases where | | | | | | | 1 | 0.36% |
| 38 | tough cases where a | | | | | | | 1 | 0.36% |
| 39 | cases where a specific | | | | | | | 1 | 0.36% |
| 40 | where a specific specialty | | | | | | | 1 | 0.36% |